Group One Trading, L.P. Neurocrine Biosciences Inc Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $517,027 - $565,743	3,951 New	3,951 $543,000
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $1.17 Million - $1.53 Million	12,470 New	12,470 $1.26 Million
Q2 2022 Aug 11, 2022	SELL	$75.79 - $100.07 $3.69 Million - $4.87 Million	-48,709 Reduced 94.6%	2,780 $271,000
Q1 2022 May 12, 2022	BUY	$72.45 - $94.81 $3.73 Million - $4.88 Million	51,489 New	51,489 $4.83 Million
Q1 2021 May 12, 2021	SELL	$87.57 - $119.4 $19,440 - $26,506	-222 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$86.91 - $108.33 $19,294 - $24,049	222 New	222 $21,000
Q3 2020 Nov 12, 2020	SELL	$96.16 - $135.15 $692,448 - $973,215	-7,201 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $494,287 - $757,261	5,809 Added 417.31%	7,201 $879,000
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $431,431 - $653,437	-5,744 Reduced 80.49%	1,392 $120,000
Q4 2019 Feb 10, 2020	SELL	$86.8 - $118.57 $105,809 - $144,536	-1,219 Reduced 14.59%	7,136 $767,000
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $286,580 - $347,028	3,419 Added 69.27%	8,355 $753,000
Q2 2019 Aug 09, 2019	BUY	$72.24 - $91.27 $150,259 - $189,841	2,080 Added 72.83%	4,936 $417,000
Q1 2019 May 13, 2019	BUY	$69.31 - $91.53 $179,582 - $237,154	2,591 Added 977.74%	2,856 $252,000
Q4 2018 Feb 06, 2019	SELL	$68.32 - $124.36 $744,346 - $1.35 Million	-10,895 Reduced 97.63%	265 $19,000
Q3 2018 Nov 08, 2018	BUY	$98.88 - $125.85 $1.1 Million - $1.4 Million	11,160 New	11,160 $1.37 Million
Q1 2018 May 11, 2018	SELL	$75.88 - $92.43 $1.22 Million - $1.49 Million	-16,092 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$58.53 - $77.59 $137,662 - $182,491	-2,352 Reduced 12.75%	16,092 $1.25 Million
Q3 2017 Nov 15, 2017	BUY	$47.97 - $61.28 $859,238 - $1.1 Million	17,912 Added 3366.92%	18,444 $1.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	532	532 $24,000

Others Institutions Holding NBIX

# of Institutions

627

Shares Held

94.3M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.8 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.27 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$654 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$327 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$237 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account